Recently, hotspot TERT promoter gene mutations have been found in gliomas, with the highest incidence in GBMs (∼60%) (Vinagre et al. 2013; Heidenreich et al. 2014; Killela et al. 2013; Batista et al. 2016). The gene discussed is TERT; the disease is central nervous system cancer.